about
Outcomes of abdominal surgery in patients with liver cirrhosisExploiting natural anti-carbohydrate antibodies for therapeutic purposesRemoval of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural alpha-galactosyl IgG antibodies.Influence of acute kidney injury on short- and long-term outcomes in patients undergoing cardiac surgery: risk factors and prognostic value of a modified RIFLE classification.Cytomegalovirus disease in intestinal transplantationInfectious complications after small bowel transplantation in adultsA prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipientsHumoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation.Prospects of clinical xenotransplantation.A randomized clinical trial for the timing of tracheotomy in critically ill patients: factors precluding inclusion in a single center study.Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer.The influence of body mass index on outcomes in patients undergoing cardiac surgery: does the obesity paradox really exist?Evaluation of the PaO2/FiO2 ratio after cardiac surgery as a predictor of outcome during hospital stayDivergence of the response induced by xenogenic immunization in the sepsis survival of rats.Age and sex differences in perioperative myocardial infarction after cardiac surgeryA randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients.Influence of cirrhosis in cardiac surgery outcomes.Detection of cytomegalovirus in formalin-fixed paraffin-embedded donor, native and allograft liver tissue using a multiplex polymerase chain reaction-liquid hybridization assay.Cytokine Profile Associated with Selective Removal of Natural Anti-αGal Antibodies in a Sepsis Model in Gal-KO Mice.TNF, pig CD86, and VCAM-1 identified as potential targets for intervention in xenotransplantation of pig chondrocytes.Lack of cross-species transmission of porcine endogenous retrovirus in pig-to-baboon xenotransplantation with sustained depletion of anti-alphagal antibodies.Characterization of immunogenic Neu5Gc in bioprosthetic heart valves.Evaluation of Serial Arterial Lactate Levels as a Predictor of Hospital and Long-Term Mortality in Patients After Cardiac Surgery.Invasive Pulmonary Aspergillosis with Disseminated Infection in Immunocompetent Patient.Liver transplantation for alcoholic liver disease: survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone.Use of the D-xylose absorption test in monitoring intestinal allograftsIntestinal transplantation and bacterial overgrowth in humans.Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantationBoosted rat natural xenoantibodies cross-react with Enterococcus faecalis by targeting melibiose and L-rhamnose.Factors associated with recurrent cytomegalovirus disease after small bowel transplantation.Complement activation correlates with graft damage in baboon-to-human liver xenotransplantationEffect of anticomplement agent K-76 COOH in hamster-to-rat and guinea pig-to-rat xenotransplantation.Vascularized bone marrow transplantation in rats: evidence for amplification of hematolymphoid chimerism and freedom from graft-versus-host reactionCurrent trends in transplantation and immunosuppressive treatment.[Transmission cytomegalovirus infection by blood transfusions]Basic and patient-oriented research in organ transplantation.Control of endemic multidrug-resistant Gram-negative bacteria after removal of sinks and implementing a new water-safe policy in an intensive care unit.0728. Removal of natural anti-galactose α1,3 galactose antibodies with GAS914 enhances humoral immunity and prevents sepsis mortality in mice.Genetic engineering strategies to prevent the effects of antibody and complement on xenogeneic chondrocytes.Bloodstream infection related to catheter connections: a prospective trial of two connection systems.
P50
Q26766070-9CA97CEA-2DE2-450D-954C-15ACEBF4177BQ26779027-CC6BE771-94A6-4980-A015-C4F8F2465AEFQ32030030-C3A48968-EF34-45AA-BE02-946648305A2DQ33752790-EB2629A0-581B-4DF8-80D7-5E9FBD1187E4Q34201148-549EEC7E-A1C6-49C0-9B8F-4F3E1F046073Q34219322-0EE90F62-15AA-4563-8D3F-0EFD358096B1Q34219755-BA247206-E43B-4EF0-869A-9A80D8CC173FQ34259588-952F1C8B-0A38-4389-8BBE-CA41F5313E89Q34291353-737940D5-39B9-4F68-9F36-391AB7C20215Q34527989-84A1B64E-42B5-4CCE-826D-361B67A20C96Q34818025-7A04B04A-1BFB-4D99-9253-83DC3DCFE896Q35187805-39DB660E-75C4-4AA8-BA1B-80FB6D33C7CEQ35619390-ACA19ECF-489A-41BF-8969-A5989C01769AQ35620023-87723CCF-4F88-4D64-A9E6-335CD008EECFQ36051743-5AD05DAE-8631-4AC7-BA78-94FFC7440D99Q37624611-BF52BC81-0BA5-4861-9244-CBB6157BD259Q38443646-D6ADD9FA-A3E3-44CA-BFEA-F592ECCFF845Q38484374-8F2B186B-8FBB-40BC-86F6-DCADE610D795Q38892970-0BDB3060-3542-44CE-93D8-A2147D93636EQ39792817-3599A193-D8F9-4141-BF28-6B72CA3F5C67Q40437214-A0145135-D351-4DF0-99E6-30405C502E5CQ40545748-B20BF195-70AF-4BD6-9567-B6EC2E8F4B72Q40592447-1BAD5E57-72BF-431B-9B96-554E85EF9C71Q40604174-6C81AA01-F418-4EFC-BEF1-EDC9285CD800Q40800221-B3997A36-9E52-4181-B1C3-AEAB335CC653Q41116284-62E93D83-D09B-4853-98E3-0BC3729F8E0AQ41432215-7FD27149-4846-4C13-8EF7-6DB2DCBF55C9Q41970570-1402A7FF-0236-4D80-A691-BBF7E403438CQ42240224-FAB73815-A068-4E87-86AA-89A9B81845E5Q42272697-631A1F65-7033-4353-96C1-2EC95EA9C15EQ42275141-9364FDB2-6A85-4B66-AC4C-DE5B6E9CED3DQ42394788-73D838ED-B5C5-4A5C-ADD1-1F541056DF83Q42722218-BB8E9A5B-F950-4660-8578-C5CC391CD44AQ44564359-621C33B1-D45D-4503-92F5-33E551656B02Q44641838-8E6ECF16-1584-4137-8849-A553E2974720Q45864930-11A93EA3-F6BE-482C-AE01-C0D78131DDB7Q47812247-944CE599-1D7B-45E6-8C9D-816BEACA6B49Q49879768-6BA932CB-E58F-4CEB-A67E-81870BA5F84DQ50911271-1C9FFFEF-A63E-4504-B28E-B92D0154B4ADQ50927468-84C269B4-70E5-4CC5-A19B-8E125CA82C04
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rafael Manez
@ast
Rafael Manez
@de
Rafael Manez
@en
Rafael Manez
@es
Rafael Manez
@nl
type
label
Rafael Manez
@ast
Rafael Manez
@de
Rafael Manez
@en
Rafael Manez
@es
Rafael Manez
@nl
prefLabel
Rafael Manez
@ast
Rafael Manez
@de
Rafael Manez
@en
Rafael Manez
@es
Rafael Manez
@nl
P106
P21
P31
P496
0000-0002-0884-5564